ARTICLE | Company News
Allist Pharmaceuticals, Prometic deal
November 1, 2010 7:00 AM UTC
Allist received exclusive rights to develop and commercialize ProMetic's PBI-1402 to treat chemotherapy-induced anemia (CIA) and cancer-related anemia and PBI-4419 to treat fibrotic diseases in Chin...